ANGLE plc, one of the world-leading liquid biopsy companies, is delighted to announce that it has signed a contract with a new customer, Crescendo Biologics Limited (Crescendo). Crescendo is a UK-based, clinical stage immuno-oncology company with an extensive proprietary pipeline of novel, targeted T cell enhancing Humabody therapeutics. Crescendo will use ANGLE’s recently launched Portrait […]
Related Articles
This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here